Suppr超能文献

COVID-19 相关动脉血栓形成和血栓栓塞的抗栓治疗:美国胸科医师学会专家小组报告。

Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19: An American College of Chest Physicians Expert Panel Report.

机构信息

School of Medicine, University of Belgrade, Belgrade, Serbia; Cardiology Clinic, University Clinical Centre of Serbia, Belgrade, Serbia.

Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL.

出版信息

Chest. 2023 Dec;164(6):1531-1550. doi: 10.1016/j.chest.2023.06.032. Epub 2023 Jun 29.

Abstract

BACKGROUND

Evidence increasingly shows that the risk of thrombotic complications in COVID-19 is associated with a hypercoagulable state. Several organizations have released guidelines for the management of COVID-19-related coagulopathy and prevention of VTE. However, an urgent need exists for practical guidance on the management of arterial thrombosis and thromboembolism in this setting.

RESEARCH QUESTION

What is the current available evidence informing the prevention and management of arterial thrombosis and thromboembolism in patients with COVID-19?

STUDY DESIGN AND METHODS

A group of approved panelists developed key clinical questions by using the Population, Intervention, Comparator, and Outcome (PICO) format that address urgent clinical questions regarding prevention and management of arterial thrombosis and thromboembolism in patients with COVID-19. Using MEDLINE via PubMed, a literature search was conducted and references were screened for inclusion. Data from included studies were summarized and reviewed by the panel. Consensus for the direction and strength of recommendations was achieved using a modified Delphi survey.

RESULTS

The review and analysis of the literature based on 11 PICO questions resulted in 11 recommendations. Overall, a low quality of evidence specific to the population with COVID-19 was found. Consequently, many of the recommendations were based on indirect evidence and prior guidelines in similar populations without COVID-19.

INTERPRETATION

The existing evidence and panel consensus do not suggest a major departure from the management of arterial thrombosis according to recommendations predating the COVID-19 pandemic. Data on the optimal strategies for prevention and management of arterial thrombosis and thromboembolism in patients with COVID-19 are sparse. More high-quality evidence is needed to inform management strategies in these patients.

摘要

背景

越来越多的证据表明,COVID-19 患者发生血栓并发症的风险与高凝状态有关。一些组织已经发布了针对 COVID-19 相关凝血障碍和预防 VTE 的管理指南。然而,目前迫切需要针对这种情况下的动脉血栓形成和血栓栓塞的管理提供实用指导。

研究问题

目前有哪些关于 COVID-19 患者预防和管理动脉血栓形成和血栓栓塞的证据?

研究设计和方法

一组经过批准的专家小组成员使用人群、干预、比较和结局(PICO)格式制定了关键的临床问题,这些问题涉及预防和管理 COVID-19 患者动脉血栓形成和血栓栓塞的紧急临床问题。通过 MEDLINE 进行了文献检索,并通过 PubMed 筛选了参考文献。由专家组对纳入研究的数据进行总结和审查。通过修改后的 Delphi 调查达成了对建议方向和强度的共识。

结果

基于 11 个 PICO 问题的文献回顾和分析得出了 11 项建议。总体而言,发现针对 COVID-19 人群的证据质量较低。因此,许多建议都是基于间接证据和没有 COVID-19 的类似人群的先前指南。

解释

现有的证据和专家组共识并不表明需要根据 COVID-19 大流行前的建议对动脉血栓形成的管理进行重大改变。关于 COVID-19 患者预防和管理动脉血栓形成和血栓栓塞的最佳策略的数据很少。需要更多高质量的证据来为这些患者的管理策略提供信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验